BSECompany Update9h ago · 18 Nov 2026, 10:57 pm
Transcript of the Earning Call - Q2 & H1 FY 27.
NGL Fine Chem Ltd · 524774
✦ AI Summary▲ PositiveResults
NGL Fine Chem Ltd has announced its Q2 and H1 FY27 earnings, with revenue from operations increasing by 32% YoY to Rs. 158.71 crores, and EBITDA margin improving to 17.68%.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
NGL Fine Chem Ltd - 524774 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Attachments (1)
📄pdf
Download →
15b59f03-2bb7-4b1e-a3b0-1ebaf7c906e5.pdf
View document text
November 18, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor, Plot No.C/1, G Block,
Dalal Street, Fort, Bandra Kurla Complex, Bandra East,
Mumbai 400 001. Mumbai 400051.
Scrip Code: 524774 Symbol: NGLFINE
Dear Sir/Madam,
Sub: Transcript of the Earnings Call – Q2 & H1 FY 27.
Dear Sir/Madam,
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we hereby submit the Transcript of the Earnings Conference Call for
Q2 & H1 FY 27 held on Thursday, November 12, 2026.
The above transcript is also being made available under the Investors Section on the
Company’s website at www.nglfinechem.com .
You are requested to kindly take the information on record.
Thanking you,
Yours faithfully,
For NGL Fine-Chem Limited
Shivam Gharat
Company Secretary and Compliance Officer
M. No.: A56704
Encl: As Above.
“NGL Fine-Chem Limited
Q2 & H1 FY’27 Earnings Conference Call”
November 12, 2026
MANAGEMENT: MR. RAHUL NACHANE
MANAGING DIRECTOR
NGL FINE-CHEM LIMITED
MR. RAJESH LAWANDE
WHOLE-TIME DIRECTOR & CFO
NGL FINE-CHEM LIMITED
Page 1 of 16
NGL Fine-Chem Limited
November 12, 2026
NGL Fine-Chem Limited
Q2 and H1 FY27 Earnings Conference Call
November 12, 2026
Disclaimer: This transcript has been prepared from the audio recording of the Earnings Conference Call held
on November 12, 2026, and has been edited for clarity, readability and grammatical accuracy. Verbal fillers,
repetitions and obvious transcription errors have been removed wherever necessary. Such editorial changes are
not intended to alter the substance or meaning of the discussions. While every effort has been made to ensure
accuracy, the transcript may not be a verbatim reproduction of the proceedings. In case of discrepancy, the audio
recordings will prevail.
Moderator: Ladies and gentlemen, good day and welcome to the Q2 and H1 FY27
Earnings Conference Call of NGL Fine-Chem Limited.
As a reminder, all participant lines will be in listen-only mode, and there will be
an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during the conference call, please signal an
operator by pressing ‘*’ followed by ‘0’ on your touchtone phone. Please note
that this conference is being recorded.
I now hand the conference over to Mr. Abhishek Mehra from TIL Advisors.
Thank you and over to you, Abhishek.
Abhishek Mehra: Thank you, Danish. Good morning, everyone, and thank you for joining this Q2
and H1 FY27 Earnings Conference Call of NGL Fine-Chem Limited.
The results and investor updates have been uploaded to the stock exchanges.
To take us through the results for the quarter and answer your questions, we
have with us today Mr. Rahul Nachane, Managing Director, and Mr. Rajesh
Lawande, Whole-Time Director and Chief Financial Officer. We will start the
call with a brief overview of the financial performance, followed by the Q&A
session.
I would like to remind you that any statements made on this call that reflect an
outlook for the future and may be construed as forward-looking statements
must be viewed in conjunction with the uncertainties and risks that the
company faces. These uncertainties and risks include, but are not limited to,
those mentioned in our annual reports. With that, I will now hand over the call
to Mr. Rahul Nachane. Over to you, sir.
Page 2 of 16
NGL Fine-Chem Limited
November 12, 2026
Rahul Nachane: Good morning, everyone, and welcome to NGL Fine-Chem Limited's Q2 and
H1 FY27 earnings call. Thank you for joining us and for reviewing our financial
results and investor presentation. Q2 was a strong quarter for NGL with higher
revenues, improved operating profitability, and continued volume growth.
We also commenced production in Phase II of our Tarapur greenfield facility
on 24 September 2026, completing the commissioning of the project. These
developments give us greater confidence in the business. At the same time,
commissioning marks the beginning of the next stage: building utilization,
completing customer and regulatory requirements, and earning an appropriate
return on the investment.
Let me first take you through our consolidated financial performance. Revenue
from operations for Q2 FY27 was Rs. 158.71 crores, an increase of 32% over
the corresponding quarter last year and 14% over Q1 FY27. Revenue also
exceeded the Rs. 149.23 crores reported in Q4 FY26. Growth continued to be
led primarily by volumes, supported by demand across our product portfolio
and markets.
EBITDA increased by 64% year-on-year to Rs. 28.06 crores. The EBITDA
margin was 17.68%, compared with 14.27% a year earlier and 16.73% in the
preceding quarter. The improvement reflects the benefit of partial price pass-
through to customers in Q1 and better absorption of fixed costs at higher
volumes. The quarter's margin was within the 15%-18% range we had
indicated earlier. We are encouraged by this performance while recognizing
that the cost of bringing new capacity into operation will influence margins over
the coming quarters.
Profit before tax was Rs. 21.60 crores, an increase of 67% year-on-year. Profit
after tax increased by 69% to Rs. 16.25 crores. On a sequential basis, profit
after tax was lower than the Rs. 18.4 crores reported in Q1. This should be
viewed alongside the change in other income, which declined from Rs. 7.43
crores to Rs. 1.20 crores, and the increase in depreciation from Rs. 5.25 crores
to Rs. 6.55 crores. Q1 had also benefited from inventory gains and favorable
foreign exchange movements, as discussed in our previous update.
At the operating level, Q2 EBITDA increased by approximately 20% over Q1.
The underlying improvement in the business is therefore stronger than the
sequential movement in reported net profit alone would suggest. In the first
half, revenue from operations was Rs. 297.87 crores, an increase of
Page 3 of 16
NGL Fine-Chem Limited
November 12, 2026
approximately 33% over H1 FY26. Profit after tax was Rs. 34.64 crores
compared with Rs. 18.87 crores in the corresponding period last year. Turning
to cash flow and the balance sheet, net cash from operating activities was Rs.
35.80 crores in the first half. Net investing outflows were Rs. 44.05 crores as
we continued expenditure towards completing the expansion. Inventories
increased from Rs. 70.28 crores at the end of March to Rs. 118.38 crores at
the end of September. This reflects higher business activity and the stock
required to support the new facility and our sales growth.
Nevertheless, the increase is significant, and working capital discipline will be
an important priority as production and sales scale up. Total borrowings were
approximately Rs. 122 crores, compared with Rs. 108 crores at the end of
FY26. Our focus now is on converting the investment in capacity and working
capital into sales, operating cash flow and improved results. Coming to
Tarapur, Phase II is operational and fully staffed. The facility provides flexibility
to manufacture existing products and support products in our development
pipeline. In the near term, we intend to use the capacity to serve demand in
our existing markets while progressing the requirements for business in
regulated markets. We currently expect utilization to reach approximately 30%-
40% over the next two to three quarters, subject to customer demand, product
mix and the pace of production ramp-up.
As utilization builds, the facility's fixed operating costs will spread over a larger
production base. Initially, however, these costs will be incurred ahead of the
full revenue contribution. Depreciation and finance costs will also affect
reported earnings as the project moves fully into operation.
We therefore expect some pressure on margins during this transition. Higher
volumes should support earnings over time, but the pace of improvement will
depend on utilization, realizations and operating efficiency. Our regulatory
program continues in parallel.
I
[Showing first 8,000 characters — download PDF for full document]